Mejorasp 3750IU Injection

About

Mejorasp 3750IU Injection contains asparaginase, an enzyme used as an antineoplastic agent, primarily in the treatment of acute lymphoblastic leukemia (ALL). Asparaginase works by depleting asparagine, a non-essential amino acid, from the bloodstream. Unlike normal cells, certain leukemic cells lack the ability to synthesize asparagine and are therefore dependent on exogenous sources. By depriving these cells of asparagine, Mejorasp inhibits protein synthesis and leads to cell death in asparagine-dependent cancer cells.

This targeted mechanism of action makes it a crucial component of multi-agent chemotherapy regimens for ALL, particularly in pediatric and adult patients. Administration is typically intramuscular or intravenous, and careful monitoring for hypersensitivity reactions and other metabolic complications is essential during treatment.

Uses

• Treatment of acute lymphoblastic leukemia (ALL)
• Part of multi-agent chemotherapy regimens
• Induction therapy for ALL
• Treatment of some non-Hodgkin lymphomas

Directions For Use

Administered intramuscularly or intravenously by a healthcare professional. Dosage and schedule are determined by your oncologist.

Benefits

• Specific mechanism targeting leukemic cells
• Crucial for ALL treatment regimens
• Effective in inducing remission
• Can be used in pediatric and adult ALL
• Part of established chemotherapy protocols
• Improves survival rates in ALL

Side Effects

• Hypersensitivity reactions (anaphylaxis)
• Pancreatitis
• Coagulopathy (bleeding or thrombosis)
• Hyperglycemia
• Liver dysfunction
• Nausea and vomiting
• Fever
• Chills
• Fatigue
• Rash
• Central nervous system effects (e.g., confusion)
• Renal dysfunction (rare)

Safety Measures

• Alcohol - Avoid alcohol consumption as it may exacerbate liver toxicity and pancreatic side effects associated with asparaginase.
• Pregnancy - Not recommended during pregnancy due to potential for fetal harm. Discuss risks and benefits with your doctor.
• Breastfeeding - Contraindicated during breastfeeding due to the potential for serious adverse effects on the infant.
• Liver - Use with caution in patients with pre-existing liver impairment. Asparaginase can cause significant liver dysfunction, requiring close monitoring.
• Kidney - Use with caution in patients with renal impairment. While not primarily renally cleared, kidney function should be monitored due to potential for metabolic disturbances.
• Lung - No specific lung-related safety concerns, but hypersensitivity reactions can manifest with respiratory symptoms (e.g., bronchospasm).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.